Skip to content

Based on the theory of ' Guben Xiezhuo ' the clinical efficacy and mechanism of Bushen Huoxue Granule in the intervention of non-dialysis patients with chronic kidney disease stage 3-5 were studied

Based on the theory of ' Guben Xiezhuo ' the clinical efficacy and mechanism of Bushen Huoxue Granule in the intervention of non-dialysis patients with chronic kidney disease stage 3-5 were studied

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001445
Enrollment
Unknown
Registered
2025-07-20
Start date
2024-05-13
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease stage 3-5 (CKD3-5)

Interventions

Sponsors

Wangjing Hospital China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) aged 18-85 years old; (2) TCM syndrome differentiation was in accordance with the TCM diagnostic criteria of "spleen and kidney deficiency blood stasis turbidity and poison syndrome"; (3) meet the diagnostic criteria of western medicine and eGFR=60 mL/min/1.73m2 (CKD3-5 stage); (4) The patient did not receive renal replacement therapy; (5) Informed consent was signed voluntarily.

Exclusion criteria

Exclusion criteria: (1) Previous history of acute cardiovascular and cerebrovascular diseases in the past six months; (2) renal replacement therapy such as blood purification and kidney transplantation has been performed; (3) Critical condition unstable vital signs and emergency dialysis indications; (4) patients currently taking corticosteroids or immunosuppressants; (5) complicated with other serious diseases such as chronic liver cirrhosis hematological diseases malignant tumors etc.; (6) there are serious psychological or mental abnormalities; (7) pregnant or lactating women; (8) Allergic constitution or allergic to multiple drugs.

Design outcomes

Primary

MeasureTime frame
Estimated glomerular filtration rate;Kauppila calcification score;Carotid intima-media thickness values;Serum creatinine;Valve calcification values;

Secondary

MeasureTime frame
Indoxyl sulfate;Symptom Score;P-cresol sulfate;Bone-specific alkaline phosphatase;Trimethylamine oxide;Intact parathyroid hormone;Type IV collagen;Serum phosphorus;Indole-3-acetic acid;Total serum calcium;Transforming growth factor ß1;Traditional Chinese medicine, Symptom, Efficacy;Renal function, Efficacy;Calcium and phosphorus product;

Countries

China

Contacts

Public ContactTongxia Li

Wangjing Hospital China Academy of Chinese Medical Sciences

litongxia0711@126.com15811353504

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026